Tailored thromboprophylaxis for patients with multiple myeloma treated by IMIDs

被引：5
|
作者：
Paydas, Semra [1 ]
机构：
[1] Cukurova Univ, Fac Med, Dept Oncol, Adana, Turkey
来源：
LEUKEMIA & LYMPHOMA | 2008年 / 49卷 / 08期
关键词：
D O I：
10.1080/10428190802187155
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1644 / 1645
页数：2
相关论文
共 50 条
  • [21] Elucidation of IMiDs-resistant mechanism in multiple myeloma
    Uozaki, Ryo
    Ichikawa, Daiju
    Matusita, Maiko
    Hattori, Yutaka
    CANCER SCIENCE, 2018, 109 : 510 - 510
  • [22] Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
    H Quach
    D Ritchie
    A K Stewart
    P Neeson
    S Harrison
    M J Smyth
    H M Prince
    Leukemia, 2010, 24 : 22 - 32
  • [23] Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
    Quach, H.
    Ritchie, D.
    Stewart, A. K.
    Neeson, P.
    Harrison, S.
    Smyth, M. J.
    Prince, H. M.
    LEUKEMIA, 2010, 24 (01) : 22 - 32
  • [24] Apixaban Is Safe and Effective Thromboprophylaxis in Myeloma Patients Treated with Immunomodulatory Therapy
    Storrar, Neill
    Mathur, Abhinav
    Johnson, Peter
    Roddie, Huw
    BLOOD, 2017, 130
  • [25] Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma
    Campos-Cabrera, Gregorio
    Mendez-Garcia, Esther
    Campos-Cabrera, Salvador
    Campos-Villagomez, Jose-Luis
    Campos-Cabrera, Virgina
    BLOOD, 2018, 132
  • [26] Risk Factors for Thromboembolism (TE) in Multiple Myeloma (MM) Patients (pts) Treated with Immunomodulatory Agents (IMiDs) Plus Dexamethasone (dex)
    Patel, Jai N.
    Jagosky, Megan Helena
    Robinson, Myra M.
    Slaughter, Daniel
    Arnall, Justin
    Matusz-Fisher, Ashley
    Bhutani, Manisha
    Voorhees, Peter M.
    Usmani, Saad Z.
    BLOOD, 2018, 132
  • [27] Thromboprophylaxis prescribing and thrombotic event rates in multiple myeloma patients treated with lenalidomide or thalidomide at a specialist cancer hospital
    Alexander, Marliese
    Teoh, Khai C.
    Lingaratnam, Senthil
    Kirsa, Sue
    Mellor, James D.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 (02) : 169 - 175
  • [28] Myeloma, IMiDs and thrombosis
    Boyle, Eileen M.
    Fouquet, Guillemette
    Manier, Salomon
    Guidez, Stephanie
    Herbaux, Charles
    Demarquette, Helene
    Leleu, Xavier
    HEMATOLOGIE, 2013, 19 (01): : 33 - 39
  • [29] Advances in maintenance treatment in multiple myeloma: the place of immunomodulators (IMiDs)
    Manier, S.
    Boyle, E.
    Gauthier, J.
    Bories, C.
    Facon, T.
    Leleu, X.
    ONCOLOGIE, 2011, 13 (09) : 553 - 558
  • [30] Prognosis of relapsed multiple myeloma after treatment by IMiDs and Bortezomib
    Fouquet, Guillemette
    Leleu, Xavier
    HEMATOLOGIE, 2011, 17 (05): : 310 - 310
12345